Industry News

Industry News

Breast Cancer Patients With Bone Metastases Benefit From Denosumab

Aug 16, 2012

Treatment with denosumab resulted in a greater reduction in skeletal-related events in patients with breast cancer that spread to the bones compared with zoledronic acid, while also maintaining health-related quality of life, according to the results of a phase III study published in Clinical Cancer Research, a journal of the American Association for Cancer Research... Read More

Cause Of Burkitt Lymphoma Discovered

Aug 15, 2012

Burkitt lymphoma is an extremely fast growing form of non-Hodgkin's lymphoma that originates from a subgroup of white blood cells called B lymphocytes of the immune system. Now, researchers at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch have discovered a vital component that converts the immune cells into malignant lymphoma cells. According to Dr... Read More

Internal Microscopic Diagnostic Devices - Clinicians Need More Training

Aug 15, 2012

To diagnose illness in areas of the body that are hard-to-reach, clinicians increasingly use tiny space age probes, which can see inside single living cells. A new study published in the journal Digestive Diseases and Sciences reveals that specialists who are beginning to use these devices may be interpreting what they see in different ways. Dr... Read More

Skin Cancer Patients Should Be Screened Before Receiving Vemurafenib

Aug 15, 2012

According to a study conducted by Cancer Research UK, different genetic mutations powering skin cancer may have an impact on how patients respond to the drug vemurafenib, meaning that individuals suffering from melanoma skin cancer should be screened prior to treatment... Read More

Improved Understanding Of TREX Could See New Treatments For Cancer, Motor Neuron Disease, Myotonic Dystrophy

Aug 15, 2012

Decoded process could hold the key to future treatments for a wide range of chronic health problems including Motor Neuron Disease, myotonic dystrophy and a wide range of cancers, University of Sheffield scientists have revealed... Read More

Physical And Psychological Well-Being Improved By Exercise During And After Cancer

Aug 15, 2012

Exercise may improve quality of life for people with cancer, according to Cochrane researchers. In two separate Cochrane systematic reviews, the authors gathered together evidence showing that activities such as walking and cycling can benefit those who are undergoing or have completed treatment for cancer... Read More

Heart Disease Risk May Be Influenced By Blood Type

Aug 15, 2012

People with blood type A, B, or AB had a higher risk for coronary heart disease when compared to those with blood type O, according to new research published in Arteriosclerosis, Thrombosis and Vascular Biology, an American Heart Association journal. People in this study with the rarest blood type - AB, found in about 7 percent of the U.S... Read More

Potential New Blood Test To Guide Treatment For Kidney Cancer

Aug 15, 2012

A common enzyme that is easily detected in blood may predict how well patients with advanced kidney cancer will respond to a specific treatment, according to doctors at Duke Cancer Institute. The finding, published online Monday, Aug. 13, 2012, in the Journal of Clinical Oncology, could lead to the first blood test to determine the best treatment for late-stage kidney cancer... Read More

Potential New Blood Test To Guide Treatment For Kidney Cancer

Aug 15, 2012

A common enzyme that is easily detected in blood may predict how well patients with advanced kidney cancer will respond to a specific treatment, according to doctors at Duke Cancer Institute. The finding, published online Monday, Aug. 13, 2012, in the Journal of Clinical Oncology, could lead to the first blood test to determine the best treatment for late-stage kidney cancer... Read More

Mechanisms Of Acquired Chemoresistance In Ovarian Cancer Identified

Aug 15, 2012

The presence of multiple ovarian cancer genomes in an individual patient and the absence or downregulation of the gene LRP1B are associated with the development of chemoresistance in women with the high-grade serous cancer subtype of ovarian cancer whose disease recurs after primary treatment... Read More

Previous Page   Next Page